Isothermal titration calorimetry, UV melting, and competition
dialysis techniques have been used to examine
the binding of isomeric 1,4- and
2,6-bis(ω-aminopropionamido)-substituted
anthracene-9,10-diones (anthraquinones)
with dA
n
·dT
n
duplexes and
dT
n
−dA
n
·dT
n
triplexes. Recent footprinting studies [Fox, K. R.; Polucci, P.;
Jenkins, T.
C.; Neidle, S. Proc. Natl. Acad. Sci.
U.S.A.
1995
,
92, 7887−7891] indicate that
2,6 derivatives, but not their 1,4
counterparts, differentially stabilize triple-stranded DNA and may have
application in antigene chemotherapy.
Thermodynamic investigations are here reported for interaction
with dA18·dT18 and
dT18−dA18·dT18. The
2,6
compound shows preferential triplex binding, with
K
b values of 1.8 × 104 M
(duplex)-1 and 2.2 × 105 M
(triplex)-1
at 25 °C in aqueous solution, pH 6.0, whereas the 1,4 isomer favors
duplex binding, with K
b values of 1.1 ×
105 M
(duplex)-1 and 3.5 × 104 M
(triplex)-1. Binding to the preferred
DNA is enthalpically driven for each ligand,
whereas binding to the disfavored DNA is either entropically
driven or enthalpy/entropy compensated. Further,
the
binding site sizes (3.6 base pairs/base triplets) suggest DNA
intercalation. Competition dialysis studies with
poly(dA)·poly(dT) and
poly(dA)·poly(dT)2 confirm these binding
preferences, and qualitative support is provided from
UV melting experiments. Such studies reveal triplex disruption by
the 1,4 isomer at low drug concentrations while
the 2,6 compound effects stabilization toward thermal triplex
denaturation. Spectrophotometric studies of each free
ligand indicate self-association in aqueous solution, with dimerization
constants at 25 °C of (2.9 ± 0.2) × 103
and
(3.2 ± 0.1) × 103 M-1
respectively for the 1,4 and 2,6 isomers. Taken together, these
data provide a firm
thermodynamic basis for the contrasting duplex/triplex binding
preferences of this isomeric family of ligands.